IRIS
CERRI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.055
AS - Asia 1.175
EU - Europa 960
SA - Sud America 171
AF - Africa 82
Continente sconosciuto - Info sul continente non disponibili 65
OC - Oceania 5
Totale 4.513
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.008
CN - Cina 434
SG - Singapore 283
IE - Irlanda 268
HK - Hong Kong 186
RU - Federazione Russa 140
BR - Brasile 124
DE - Germania 110
IT - Italia 110
VN - Vietnam 103
FI - Finlandia 84
FR - Francia 61
ZA - Sudafrica 60
GB - Regno Unito 46
UA - Ucraina 38
IN - India 34
BD - Bangladesh 25
CA - Canada 24
SE - Svezia 20
CZ - Repubblica Ceca 19
AR - Argentina 15
JP - Giappone 15
MX - Messico 14
IQ - Iraq 13
CO - Colombia 11
ES - Italia 10
NL - Olanda 10
PK - Pakistan 10
PL - Polonia 10
ID - Indonesia 9
AT - Austria 8
MA - Marocco 8
BE - Belgio 7
SA - Arabia Saudita 7
TR - Turchia 7
LT - Lituania 6
MU - Mauritius 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
CL - Cile 4
EC - Ecuador 4
KR - Corea 4
PH - Filippine 4
VE - Venezuela 4
IL - Israele 3
JM - Giamaica 3
PY - Paraguay 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
EG - Egitto 2
GE - Georgia 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MR - Mauritania 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
Totale 4.448
Salva come PNG Salva come JPEG
Città #
Chandler 289
Dublin 268
San Jose 240
Ashburn 234
Hong Kong 183
Dallas 170
Singapore 142
Beijing 120
Boardman 61
Los Angeles 61
Johannesburg 56
Helsinki 54
Council Bluffs 53
New York 49
Jacksonville 45
Princeton 45
Lawrence 44
Lauterbourg 41
Shanghai 37
Munich 36
Ho Chi Minh City 33
Medford 33
Wilmington 30
Hanoi 29
Milan 26
Santa Clara 26
Nanjing 23
São Paulo 23
The Dalles 20
Orem 19
Buffalo 18
Chicago 18
Moscow 18
Redondo Beach 18
Brno 16
Changsha 14
Nanchang 14
Tokyo 14
Shenyang 13
Pavia 12
Rome 12
Tianjin 12
Washington 12
Atlanta 10
Hebei 10
Turku 10
Columbus 9
Fairfield 9
Hangzhou 9
London 9
Warsaw 9
Chennai 8
Jiaxing 8
New Delhi 8
Nuremberg 8
Rio de Janeiro 8
Denver 7
Düsseldorf 7
Seattle 7
Stockholm 7
Toronto 7
Brooklyn 6
Brussels 6
Frankfurt am Main 6
Lahore 6
Mexico City 6
Montreal 6
Norwalk 6
Amsterdam 5
Boston 5
Da Nang 5
Guangzhou 5
Manchester 5
Phoenix 5
Piscataway 5
Poplar 5
Shijiazhuang 5
Tashkent 5
Baku 4
Bogotá 4
Can Tho 4
Falls Church 4
Florence 4
Giessen 4
Hải Dương 4
Las Vegas 4
Mumbai 4
Ningbo 4
San Francisco 4
Woodbridge 4
Ankara 3
Campinas 3
Des Moines 3
Houston 3
Montevideo 3
Naples 3
Querétaro 3
Riyadh 3
Seoul 3
Turin 3
Totale 3.001
Salva come PNG Salva come JPEG
Nome #
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 144
Immediate early genes regulation in rat cerebellar cortex during long-term synaptic plasticity induction. 134
Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: Relevance to gastrointestinal dysfunctions in Parkinson's disease 131
Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer 130
Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein. 125
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease 125
Postnatal development of Central Nervous System: anomalies in the formation of cerebellum fissures 115
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease 115
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease 115
Effects of cisplatin on neuronal cell B50: involvement of mitochondria in apoptosis induction. 114
An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease 112
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 107
Cell proliferation and death in the brain of active and hibernating frogs 107
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease 106
Developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum 104
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat 103
In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease 99
Inefficient DNA Repair Is an Aging-Related Modifier of Parkinson's Disease 99
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 98
Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease 96
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease 95
Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson’s disease, focusing on cell distribution and neuroprotective and behavioral effects 95
Repurposing opportunities for Parkinson’s disease therapies 95
Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease 95
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat 94
Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity 94
The insect brain as a model to investigate the PCB effects. Changes of NOS-dependent NADPH diaphorase activity in Blattella germanica 93
Mitochondrial Complex i Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease 92
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease 92
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease 92
Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine 90
Interactions of neurotransmitter systems during postnatal development of the rat hippocampal formation: effects of cisplatin 87
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration 85
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease 85
The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients 84
Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease 82
Potential therapeutic effects of polyphenols in Parkinson's disease: In vivo and in vitro pre-clinical studies 77
Parkinson's Disease in Women and Men: What's the Difference? 66
Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: Implications for reparative therapy in Parkinson's disease 65
Impaired Mitochondrial Respiration in REM-Sleep Behavior Disorder: A Biomarker of Parkinson's Disease? 64
Investigation and Comparison of Active and Passive Encapsulation Methods for Loading Proteins into Liposomes 59
Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias 58
Peripheral-central neuroimmune crosstalk in parkinson’s disease: What do patients and animal models tell us? 57
Profiling the Biochemical Signature of GBA-Related Parkinson's Disease in Peripheral Blood Mononuclear Cells 56
Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease 56
Role of autophagy in Parkinson’s disease 50
In vivo modeling of prodromal stage of Parkinson's disease 47
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 45
Parkinson’s disease 43
RAB32 mutation in Parkinson's disease [2] 26
Physical exercise modulates plasma irisin levels in endurance athletes: Implications for Parkinson's disease 6
Elevated plasma neurofilament light chain in isolated REM sleep behavior disorder: Associations with neurogenic orthostatic hypotension and implications for phenoconversion 5
Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarker 4
Totale 4.513
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.086
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.086
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022189 0 1 3 0 1 5 2 11 10 0 33 123
2022/2023757 91 80 15 55 58 62 0 41 328 3 17 7
2023/2024362 54 50 14 15 27 96 20 22 6 14 28 16
2024/2025862 48 64 28 21 21 60 42 53 210 48 119 148
2025/20261.860 134 118 207 194 259 66 371 118 164 125 37 67
2026/2027113 50 63 0 0 0 0 0 0 0 0 0 0
Totale 4.513